Infectious risk in multiple sclerosis patients treated with disease-modifying therapies: A three-year observational cohort study

BACKGROUND: The disease-modifying therapies (DMTs) largely used in multiple sclerosis (MS) may result in higher infectious risk. OBJECTIVE: We aimed to investigate the infectious risk in DMT-treated MS patients. METHODS: MS patients were evaluated for infectious risk before starting, switching or du...

Descripción completa

Detalles Bibliográficos
Autores principales: Zingaropoli, Maria Antonella, Pasculli, Patrizia, Iannetta, Marco, Perri, Valentina, Tartaglia, Matteo, Crisafulli, Sebastiano Giuseppe, Merluzzo, Chiara, Baione, Viola, Mazzochi, Lorenzo, Taglietti, Ambra, Pauri, Flavia, Frontoni, Marco, Altieri, Marta, Gaeta, Aurelia, Antonelli, Guido, Conte, Antonella, Mastroianni, Claudio Maria, Ciardi, Maria Rosa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733376/
https://www.ncbi.nlm.nih.gov/pubmed/35003758
http://dx.doi.org/10.1177/20552173211065731

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733376/
https://www.ncbi.nlm.nih.gov/pubmed/35003758
http://dx.doi.org/10.1177/20552173211065731

Ejemplares similares